Investor Database — 54,000+ VC, PE & angel contacts, the full list for $19.Get the list

Aglaia Oncology Funds

VC Utrecht, Netherlands ·Founded 2004

Overview

Aglaia is an oncology specialist investor which selects and matures early-stage breakthrough inventions that have the potential to transform cancer prevention, diagnosis and therapy. The Aglaia team has decades of experience in cancer research and oncology drug development and has a track record in building successful biotech companies that focus on oncology drug development.

Investment Focus

Focus on early-stage oncology drug development
Commitment to impact investing
Collaboration with innovators and entrepreneurs
Emphasis on improving patient outcomes and quality of life
Transparency and accountability in reporting social impact alongside financial performance

Portfolio Companies

argenxOncoOneInteRNA TechnologiesMIMETASMediomics

Get the full list of 54,000+ investors

Aglaia Oncology Funds and every other firm and angel in the database — as one spreadsheet you keep.

$19one-time payment · no subscription

All 54,000+ investors — VC firms, private equity, family offices and angels
The key person to contact at each one, with their job title
Their work email address
Their phone number
Their LinkedIn profile
Delivered as a single .xlsx file — download it as many times as you like

Get the full list — $19 → One payment. No seats, no credits, no expiry. Already bought it? Sign in to download it again — no second payment.

Every profile on this site is one row of the file, with the contact details masked — browse a few before you buy.

Frequently asked questions about Aglaia Oncology Funds

What sectors does Aglaia Oncology Funds invest in?

Aglaia Oncology Funds invests in Healthcare, Life Sciences, Pharmaceuticals, Medical Devices, Diagnostics and Biotechnology, and is based in Utrecht, Netherlands. Aglaia Oncology Funds is listed as a vc in the ConnectSafely investor database.